---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-26-000377"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:36:34.197101+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lifeloc FY 2025 revenue up 6% to $9.027M; net loss widens to $2.47M on deferred tax charge

## Summary
- Revenue $9.027M (+6% YoY); net loss $2.470M ($0.90/diluted share) vs $1.053M loss in 2024.
- Gross margin stable at 40.3%; pre-tax loss improved to $1.311M from $1.405M.
- Deferred tax valuation allowance increased to $1.738M (non-cash) from $187K.
- SpinDetect drug analyzer: production mold fabrication started Q1 2026; first articles expected April.
- New L-series breath testers (LX9, LT7) certified to AS 3547:2019; driving market penetration.

## SEC filing metadata
- accession: 0001079973-26-000377
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997326000377/0001079973-26-000377-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997326000377/lctc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-26-000377
- JSON: https://secwatch.observer/filing/0001079973-26-000377.json
- Plain text: https://secwatch.observer/filing/0001079973-26-000377.txt

## Key facts
- Earnings Releases
  Lifeloc Technologies, Inc reported year ended December 31, 2025 results: revenue $9.027 million, net income ($2.470) million, EPS ($0.90) per diluted share.
  - Period: year ended December 31, 2025
  - Revenue: $9.027 million
  - Net income: ($2.470) million
  - EPS: ($0.90) per diluted share
  - Result: reported results
  source text: devices, has announced financial results for the 2025 fiscal year ended December 31, 2025. 2025 Financial Highlights Lifeloc Technologies reported revenue growth of 6% to $9.027 million for 2025, compared to net revenue of $8.538 million for 2024. We realized a net loss of ($2.470) million , or ($0.90) per diluted share for the year ending December 31, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1493137/000107997326000377/0001079973-26-000377-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.